{"id":14961,"date":"2026-10-26T13:08:44","date_gmt":"2026-10-26T12:08:44","guid":{"rendered":"https:\/\/bict.it\/?p=14961"},"modified":"2026-11-04T11:48:29","modified_gmt":"2026-11-04T10:48:29","slug":"when-a-ketoreductase-beats-a-chemical-reduction","status":"publish","type":"post","link":"https:\/\/bict.it\/en\/when-a-ketoreductase-beats-a-chemical-reduction\/","title":{"rendered":"When a ketoreductase beats a chemical reduction"},"content":{"rendered":"<p>Reducing a ketone to a chiral alcohol is one of the most common steps in a synthetic route, and there is almost always more than one way to do it. The question is not which route is more modern. It is which one closes the balance better, on that ketone, at the scale you actually run.<\/p>\n<h2>The short answer<\/h2>\n<p>A ketoreductase is worth it when the stereocentre is the problem. The chemical route reaches the alcohol easily enough, but reaching it <strong>enantiopure<\/strong> asks for a chiral catalyst, a stoichiometric reagent such as (&#8722;)-DIP-Cl, or a downstream resolution that discards half the material. The enzyme puts the selectivity inside the step: it discriminates between the two faces of the carbonyl and delivers the Prelog or anti-Prelog alcohol depending on the enzyme, in water, at 25-35 \u00b0C and near-neutral pH. On the atorvastatin intermediate, the one case where the process is published in full, that means <strong>over 99.5% enantiomeric excess at 160 g\/L substrate loading and 96% isolated yield<\/strong>.<\/p>\n<p>It is worth much less when there is no stereocentre, when the ketone stays insoluble even in a biphasic system and the enzyme will not tolerate the cosolvent it would take, or when the annual volume does not amortise the development. Three honest no&#8217;s, and all three are recognisable before you spend.<\/p>\n<h2>What actually makes the difference<\/h2>\n<p>Four things, in order of weight on the balance.<\/p>\n<p><strong>Selectivity is created in the step, not after it.<\/strong> A classical kinetic resolution has a theoretical ceiling of 50% yield on the enantiomer you want; the rest has to be racemised or discarded. An enzymatic reduction starts from the prochiral ketone: it is a desymmetrisation, and the theoretical ceiling is 100%. That jump shows up first in material cost, and no downstream optimisation recovers it.<\/p>\n<p><strong>Metals leave the process.<\/strong> With no ruthenium or rhodium catalyst there is no transition-metal residue to chase with scavengers or chromatography, and none to justify in the risk assessment under ICH Q3D. On an API that is a chapter of the dossier you never open, not a nuance.<\/p>\n<p><strong>Conditions come down, and the E factor with them.<\/strong> Water or water with a cosolvent, 25-35 \u00b0C, atmospheric pressure: no hydrogen under pressure, no cryogenics, no hydrides to quench. It changes the reactor you need and it changes the safety assessment of the step. On the atorvastatin case the reported mass balance is an <strong>E factor of 5.8 excluding process water<\/strong>, 18 including it, with butyl acetate recovered at 85%.<\/p>\n<p><strong>You can choose either enantiomer, and the enzyme can be pushed.<\/strong> The initial screening covers enzymes of opposite selectivity: the target decides which one, not the chemistry you happen to have. And where the wild type falls short, directed evolution moves the limit by orders of magnitude: in the atorvastatin process the halohydrin dehalogenase that performs the cyanation was improved <strong>more than 2,500-fold<\/strong> over the starting enzyme.<\/p>\n<h2>What it costs<\/h2>\n<p>The cost is not the enzyme. It sits in three items that belong in the budget from the start.<\/p>\n<p><strong>Cofactor regeneration.<\/strong> NAD(P)H is never used stoichiometrically: it would cost more than the product. It is regenerated in two ways \u2014 a second enzyme with its sacrificial substrate (glucose dehydrogenase with glucose, formate dehydrogenase with formate), or the ketoreductase itself oxidising isopropanol to acetone. The first is more robust and adds an enzyme and a by-product to separate; the second is simpler and requires removing acetone to drive the equilibrium. That choice is a process decision, not a bench one, and it is made by looking at the total turnover number the cofactor has to sustain: that, not the catalogue price of NADPH, decides whether the item weighs. It is the first number we look at when we open a <a href=\"https:\/\/bict.it\/en\/divisions\/bioindustry\/bioindustry-rd-services\/bioindustry-biocatalytic-development\/stereoselective-reductions\/\">stereoselective reduction<\/a>.<\/p>\n<p><strong>Substrate loading.<\/strong> An enzyme that performs beautifully at 5 g\/L and collapses at 80 has not solved the problem: it has moved the bottleneck to reactor volume. The sustainable loading, the productivity in g\/L per hour that follows from it and the substrate-to-catalyst ratio are the numbers on which the two routes are really compared. For scale: the published atorvastatin process runs at 160 g\/L with 0.57 g\/L of ketoreductase, about 280 grams of ketone per gram of enzyme \u2014 a ratio derived from the two reported figures.<\/p>\n<p><strong>Development.<\/strong> Screening, choice of the regeneration system, tuning of the conditions, immobilisation if the enzyme is to be reused. That is time, and it amortises over volume: below a certain annual quantity, an already validated chemical route stays the right answer.<\/p>\n<h2>Two cases where the numbers are public<\/h2>\n<p>Almost every industrial enzymatic reduction stays inside a dossier. Two do not, and they are the two worth holding on to, because they stand for two different starting points.<\/p>\n<p><strong>Atorvastatin, where biocatalysis rewrites two steps.<\/strong> The intermediate is ethyl (R)-4-cyano-3-hydroxybutyrate. A ketoreductase reduces ethyl 4-chloroacetoacetate to the enantiopure chlorohydrin, with a glucose dehydrogenase regenerating NADPH on glucose; a halohydrin dehalogenase then replaces the chloride with cyanide, in water at neutral pH, instead of a cyanation run under far harsher conditions. The reported figures: <strong>160 g\/L loading, over 99.5% enantiomeric excess, 96% isolated yield<\/strong> on the reduction; 140 g\/L and 92% on the cyanation; an <strong>E factor of 5.8<\/strong> excluding process water. It is the process that won the Greener Reaction Conditions Award of the Presidential Green Chemistry Challenge in 2006, and it is covered by US 7,807,423 B2.<\/p>\n<p><strong>Montelukast, where it displaces a stoichiometric chiral reagent.<\/strong> Here the ketoreductase reduces a benzoate ketone to the (S)-alcohol, and the title of the process paper says exactly what replaces what: it is an alternative to the asymmetric reduction mediated by <strong>(&#8722;)-DIP-Cl<\/strong>, a chiral borane used stoichiometrically and at low temperature. Substrate and product are named in full in WO 2009\/042984 A1.<\/p>\n<p>The second situation is the one most people who write to us are in: not a process to rewrite, but an expensive chiral reagent to get rid of.<\/p>\n<h2>How to tell whether your reduction is a candidate<\/h2>\n<p>Four questions, in order.<\/p>\n<ol>\n<li><strong>Does the product have a stereocentre you need pure?<\/strong> If not, the enzyme rarely repays the development.<\/li>\n<li><strong>How do you get it today?<\/strong> Asymmetric hydrogenation with a chiral catalyst, borane reduction, or a downstream resolution: the three starting points give very different balances, and the third is where the comparison is sharpest.<\/li>\n<li><strong>Is the ketone workable in water, with a cosolvent or in a biphasic system?<\/strong> Solubility is the first real constraint, long before selectivity.<\/li>\n<li><strong>At what scale, and to what purity specification?<\/strong> Volume decides the payback, the specification decides how much purification you save.<\/li>\n<\/ol>\n<p>If the first three answers are yes, a feasibility study is worth running. If the fourth says a few tens of kilos a year, it probably is not.<\/p>\n<h2>How we work<\/h2>\n<p>We start from the ketone and the enantiomer you need. A screening of enzymes and microorganisms looks for the right selectivity; the cofactor regeneration system is chosen; the reaction is taken to process conditions, raising the loading to where the enzyme still holds. What you get back is a sheet with the numbers a decision needs: conversion and enantiomeric excess, substrate loading and productivity per litre of reactor, cofactor turnovers and biocatalyst cost per kilo of product, impurity profile against the chemical route.<\/p>\n<p>When the step is one piece of a longer route, the enzymatic reduction is fitted into the route you already have, without rewriting it.<\/p>\n<h2>From here<\/h2>\n<p>The conclusion, plainly: if your pure enantiomer comes from a resolution today, the comparison almost always turns in the enzyme&#8217;s favour, because the 50% you discard is a structural cost and cannot be optimised away. If it comes from a stoichiometric chiral reagent, the montelukast case says it can be removed. If it comes from an asymmetric hydrogenation that is already validated and runs at low catalyst loading, you need volume to amortise the development \u2014 and the question shifts from yield to metal residues and to the safety of the step.<\/p>\n<p>The question to start from is not &#8220;is biocatalysis right for us&#8221;, but &#8220;on this reaction, what are the numbers&#8221;. If you have a ketone and an enantiomeric excess specification, <a href=\"https:\/\/bict.it\/en\/divisions\/bioindustry\/bioindustry-rd-services\/bioindustry-biocatalytic-development\/stereoselective-reductions\/\">tell us where you start<\/a>: the answer is a proposal with those numbers in it.<\/p>\n<h2>Frequently asked questions<\/h2>\n<h3>How large does the volume have to be for the enzymatic route to pay?<\/h3>\n<p>There is no threshold that holds for everyone: it depends on what the pure enantiomer costs you today. Where the current route is a resolution that discards half the material, the comparison turns early; where an asymmetric hydrogenation already works well, more volume is needed to amortise the development. The honest way to answer is to compare the two costs per kilo of finished product, not per kilo of catalyst.<\/p>\n<h3>What if the ketone is not soluble in water?<\/h3>\n<p>That is the most frequent case, and it does not close the door. You work with a miscible cosolvent or in a biphasic system, where the organic phase acts as a substrate reservoir and the enzyme stays in water. The real constraint is how much solvent the enzyme tolerates before it loses activity: that is measured in the screening, not assumed.<\/p>\n<h3>Can the enzyme be reused?<\/h3>\n<p>Yes, if it is immobilised on a support, and then the biocatalyst cost divides by the number of cycles it withstands. It pays when the enzyme is the heavy item in the balance and the process is repetitive; on a single campaign the extra step often is not worth it. We assess it together with the choice of the regeneration system.<\/p>\n<h2>Sources<\/h2>\n<ul>\n<li>S. K. Ma, J. Gruber, C. Davis, L. Newman, D. Gray, A. Wang, J. Grate, G. W. Huisman, R. A. Sheldon, <em>A green-by-design biocatalytic process for atorvastatin intermediate<\/em>, Green Chemistry, 2010. DOI <a href=\"https:\/\/doi.org\/10.1039\/b919115c\" rel=\"noopener\" target=\"_blank\">10.1039\/b919115c<\/a><\/li>\n<li><a href=\"https:\/\/patents.google.com\/patent\/US7807423\" rel=\"noopener\" target=\"_blank\">US 7,807,423 B2<\/a> \u2014 <em>Enzymatic processes for the production of 4-substituted 3-hydroxybutyric acid derivatives<\/em>, Codexis<\/li>\n<li><a href=\"https:\/\/patents.google.com\/patent\/WO2009042984A1\/en\" rel=\"noopener\" target=\"_blank\">WO 2009\/042984 A1<\/a> \u2014 <em>Ketoreductase polypeptides and uses thereof<\/em>, Codexis<\/li>\n<li><a href=\"https:\/\/19january2021snapshot.epa.gov\/greenchemistry\/presidential-green-chemistry-challenge-2006-greener-reaction-conditions-award_.html\" rel=\"noopener\" target=\"_blank\">Presidential Green Chemistry Challenge, 2006 Greener Reaction Conditions Award<\/a>, US EPA<\/li>\n<\/ul>\n","protected":false},"excerpt":{"rendered":"<p>Ketoreductase or chemical route: enantiomeric excess, substrate loading, cofactor regeneration and metal residues, with figures from the published atorvastatin and montelukast processes.<\/p>\n","protected":false},"author":7,"featured_media":15083,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[79],"tags":[87],"class_list":["post-14961","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-bioindustry-en","tag-insight"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.8 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Ketoreductase or chemical reduction: how to choose | BiCT<\/title>\n<meta name=\"description\" content=\"When a ketoreductase beats the chemical route: enantiomeric excess, substrate loading, cofactor and metal residues, with figures from published processes.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/bict.it\/en\/when-a-ketoreductase-beats-a-chemical-reduction\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Ketoreductase or chemical reduction: how to choose | BiCT\" \/>\n<meta property=\"og:description\" content=\"When a ketoreductase beats the chemical route: enantiomeric excess, substrate loading, cofactor and metal residues, with figures from published processes.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/bict.it\/en\/when-a-ketoreductase-beats-a-chemical-reduction\/\" \/>\n<meta property=\"og:site_name\" content=\"Bict\" \/>\n<meta property=\"article:published_time\" content=\"2026-10-26T12:08:44+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-11-04T10:48:29+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/bict.it\/wp-content\/uploads\/2026\/11\/ketoreductase-card-en-v3.png\" \/>\n\t<meta property=\"og:image:width\" content=\"1200\" \/>\n\t<meta property=\"og:image:height\" content=\"630\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"elisa-bict\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"elisa-bict\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"8 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/bict.it\\\/en\\\/when-a-ketoreductase-beats-a-chemical-reduction\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/bict.it\\\/en\\\/when-a-ketoreductase-beats-a-chemical-reduction\\\/\"},\"author\":{\"name\":\"elisa-bict\",\"@id\":\"https:\\\/\\\/bict.it\\\/#\\\/schema\\\/person\\\/236f38e7137ba2000813ad139ae10c28\"},\"headline\":\"When a ketoreductase beats a chemical reduction\",\"datePublished\":\"2026-10-26T12:08:44+00:00\",\"dateModified\":\"2026-11-04T10:48:29+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/bict.it\\\/en\\\/when-a-ketoreductase-beats-a-chemical-reduction\\\/\"},\"wordCount\":1660,\"publisher\":{\"@id\":\"https:\\\/\\\/bict.it\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/bict.it\\\/en\\\/when-a-ketoreductase-beats-a-chemical-reduction\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/bict.it\\\/wp-content\\\/uploads\\\/2026\\\/11\\\/ketoreductase-card-en-v3.png\",\"keywords\":[\"Insight\"],\"articleSection\":[\"Bioindustry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/bict.it\\\/en\\\/when-a-ketoreductase-beats-a-chemical-reduction\\\/\",\"url\":\"https:\\\/\\\/bict.it\\\/en\\\/when-a-ketoreductase-beats-a-chemical-reduction\\\/\",\"name\":\"Ketoreductase or chemical reduction: how to choose | BiCT\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/bict.it\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/bict.it\\\/en\\\/when-a-ketoreductase-beats-a-chemical-reduction\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/bict.it\\\/en\\\/when-a-ketoreductase-beats-a-chemical-reduction\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/bict.it\\\/wp-content\\\/uploads\\\/2026\\\/11\\\/ketoreductase-card-en-v3.png\",\"datePublished\":\"2026-10-26T12:08:44+00:00\",\"dateModified\":\"2026-11-04T10:48:29+00:00\",\"description\":\"When a ketoreductase beats the chemical route: enantiomeric excess, substrate loading, cofactor and metal residues, with figures from published processes.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/bict.it\\\/en\\\/when-a-ketoreductase-beats-a-chemical-reduction\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/bict.it\\\/en\\\/when-a-ketoreductase-beats-a-chemical-reduction\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/bict.it\\\/en\\\/when-a-ketoreductase-beats-a-chemical-reduction\\\/#primaryimage\",\"url\":\"https:\\\/\\\/bict.it\\\/wp-content\\\/uploads\\\/2026\\\/11\\\/ketoreductase-card-en-v3.png\",\"contentUrl\":\"https:\\\/\\\/bict.it\\\/wp-content\\\/uploads\\\/2026\\\/11\\\/ketoreductase-card-en-v3.png\",\"width\":1200,\"height\":630,\"caption\":\"Reaction scheme: from prochiral ketone to enantiopure alcohol with a ketoreductase, at 160 g\\\/L loading and ee above 99.5%.\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/bict.it\\\/en\\\/when-a-ketoreductase-beats-a-chemical-reduction\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/bict.it\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"When a ketoreductase beats a chemical reduction\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/bict.it\\\/#website\",\"url\":\"https:\\\/\\\/bict.it\\\/\",\"name\":\"Bict\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/bict.it\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/bict.it\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/bict.it\\\/#organization\",\"name\":\"BICT SRL \u2013 BIOLOGICAL AND CHEMICAL TECHNOLOGIES\",\"url\":\"https:\\\/\\\/bict.it\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/bict.it\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/bict.it\\\/wp-content\\\/uploads\\\/2021\\\/10\\\/bict-logo-divisioni-azienda-biotech-biotecnologia-fornitori-lattoferrina-main-site@2x.png\",\"contentUrl\":\"https:\\\/\\\/bict.it\\\/wp-content\\\/uploads\\\/2021\\\/10\\\/bict-logo-divisioni-azienda-biotech-biotecnologia-fornitori-lattoferrina-main-site@2x.png\",\"width\":351,\"height\":167,\"caption\":\"BICT SRL \u2013 BIOLOGICAL AND CHEMICAL TECHNOLOGIES\"},\"image\":{\"@id\":\"https:\\\/\\\/bict.it\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/bict.it\\\/#\\\/schema\\\/person\\\/236f38e7137ba2000813ad139ae10c28\",\"name\":\"elisa-bict\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/138100720223ff1b22109a7a63ce579184abe7787dcc62f94550e8a5dd5d9e26?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/138100720223ff1b22109a7a63ce579184abe7787dcc62f94550e8a5dd5d9e26?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/138100720223ff1b22109a7a63ce579184abe7787dcc62f94550e8a5dd5d9e26?s=96&d=mm&r=g\",\"caption\":\"elisa-bict\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Ketoreductase or chemical reduction: how to choose | BiCT","description":"When a ketoreductase beats the chemical route: enantiomeric excess, substrate loading, cofactor and metal residues, with figures from published processes.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/bict.it\/en\/when-a-ketoreductase-beats-a-chemical-reduction\/","og_locale":"en_US","og_type":"article","og_title":"Ketoreductase or chemical reduction: how to choose | BiCT","og_description":"When a ketoreductase beats the chemical route: enantiomeric excess, substrate loading, cofactor and metal residues, with figures from published processes.","og_url":"https:\/\/bict.it\/en\/when-a-ketoreductase-beats-a-chemical-reduction\/","og_site_name":"Bict","article_published_time":"2026-10-26T12:08:44+00:00","article_modified_time":"2026-11-04T10:48:29+00:00","og_image":[{"width":1200,"height":630,"url":"https:\/\/bict.it\/wp-content\/uploads\/2026\/11\/ketoreductase-card-en-v3.png","type":"image\/png"}],"author":"elisa-bict","twitter_card":"summary_large_image","twitter_misc":{"Written by":"elisa-bict","Est. reading time":"8 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/bict.it\/en\/when-a-ketoreductase-beats-a-chemical-reduction\/#article","isPartOf":{"@id":"https:\/\/bict.it\/en\/when-a-ketoreductase-beats-a-chemical-reduction\/"},"author":{"name":"elisa-bict","@id":"https:\/\/bict.it\/#\/schema\/person\/236f38e7137ba2000813ad139ae10c28"},"headline":"When a ketoreductase beats a chemical reduction","datePublished":"2026-10-26T12:08:44+00:00","dateModified":"2026-11-04T10:48:29+00:00","mainEntityOfPage":{"@id":"https:\/\/bict.it\/en\/when-a-ketoreductase-beats-a-chemical-reduction\/"},"wordCount":1660,"publisher":{"@id":"https:\/\/bict.it\/#organization"},"image":{"@id":"https:\/\/bict.it\/en\/when-a-ketoreductase-beats-a-chemical-reduction\/#primaryimage"},"thumbnailUrl":"https:\/\/bict.it\/wp-content\/uploads\/2026\/11\/ketoreductase-card-en-v3.png","keywords":["Insight"],"articleSection":["Bioindustry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/bict.it\/en\/when-a-ketoreductase-beats-a-chemical-reduction\/","url":"https:\/\/bict.it\/en\/when-a-ketoreductase-beats-a-chemical-reduction\/","name":"Ketoreductase or chemical reduction: how to choose | BiCT","isPartOf":{"@id":"https:\/\/bict.it\/#website"},"primaryImageOfPage":{"@id":"https:\/\/bict.it\/en\/when-a-ketoreductase-beats-a-chemical-reduction\/#primaryimage"},"image":{"@id":"https:\/\/bict.it\/en\/when-a-ketoreductase-beats-a-chemical-reduction\/#primaryimage"},"thumbnailUrl":"https:\/\/bict.it\/wp-content\/uploads\/2026\/11\/ketoreductase-card-en-v3.png","datePublished":"2026-10-26T12:08:44+00:00","dateModified":"2026-11-04T10:48:29+00:00","description":"When a ketoreductase beats the chemical route: enantiomeric excess, substrate loading, cofactor and metal residues, with figures from published processes.","breadcrumb":{"@id":"https:\/\/bict.it\/en\/when-a-ketoreductase-beats-a-chemical-reduction\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/bict.it\/en\/when-a-ketoreductase-beats-a-chemical-reduction\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/bict.it\/en\/when-a-ketoreductase-beats-a-chemical-reduction\/#primaryimage","url":"https:\/\/bict.it\/wp-content\/uploads\/2026\/11\/ketoreductase-card-en-v3.png","contentUrl":"https:\/\/bict.it\/wp-content\/uploads\/2026\/11\/ketoreductase-card-en-v3.png","width":1200,"height":630,"caption":"Reaction scheme: from prochiral ketone to enantiopure alcohol with a ketoreductase, at 160 g\/L loading and ee above 99.5%."},{"@type":"BreadcrumbList","@id":"https:\/\/bict.it\/en\/when-a-ketoreductase-beats-a-chemical-reduction\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/bict.it\/en\/"},{"@type":"ListItem","position":2,"name":"When a ketoreductase beats a chemical reduction"}]},{"@type":"WebSite","@id":"https:\/\/bict.it\/#website","url":"https:\/\/bict.it\/","name":"Bict","description":"","publisher":{"@id":"https:\/\/bict.it\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/bict.it\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/bict.it\/#organization","name":"BICT SRL \u2013 BIOLOGICAL AND CHEMICAL TECHNOLOGIES","url":"https:\/\/bict.it\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/bict.it\/#\/schema\/logo\/image\/","url":"https:\/\/bict.it\/wp-content\/uploads\/2021\/10\/bict-logo-divisioni-azienda-biotech-biotecnologia-fornitori-lattoferrina-main-site@2x.png","contentUrl":"https:\/\/bict.it\/wp-content\/uploads\/2021\/10\/bict-logo-divisioni-azienda-biotech-biotecnologia-fornitori-lattoferrina-main-site@2x.png","width":351,"height":167,"caption":"BICT SRL \u2013 BIOLOGICAL AND CHEMICAL TECHNOLOGIES"},"image":{"@id":"https:\/\/bict.it\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/bict.it\/#\/schema\/person\/236f38e7137ba2000813ad139ae10c28","name":"elisa-bict","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/138100720223ff1b22109a7a63ce579184abe7787dcc62f94550e8a5dd5d9e26?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/138100720223ff1b22109a7a63ce579184abe7787dcc62f94550e8a5dd5d9e26?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/138100720223ff1b22109a7a63ce579184abe7787dcc62f94550e8a5dd5d9e26?s=96&d=mm&r=g","caption":"elisa-bict"}}]}},"_links":{"self":[{"href":"https:\/\/bict.it\/en\/wp-json\/wp\/v2\/posts\/14961","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/bict.it\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/bict.it\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/bict.it\/en\/wp-json\/wp\/v2\/users\/7"}],"replies":[{"embeddable":true,"href":"https:\/\/bict.it\/en\/wp-json\/wp\/v2\/comments?post=14961"}],"version-history":[{"count":1,"href":"https:\/\/bict.it\/en\/wp-json\/wp\/v2\/posts\/14961\/revisions"}],"predecessor-version":[{"id":14962,"href":"https:\/\/bict.it\/en\/wp-json\/wp\/v2\/posts\/14961\/revisions\/14962"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/bict.it\/en\/wp-json\/wp\/v2\/media\/15083"}],"wp:attachment":[{"href":"https:\/\/bict.it\/en\/wp-json\/wp\/v2\/media?parent=14961"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/bict.it\/en\/wp-json\/wp\/v2\/categories?post=14961"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/bict.it\/en\/wp-json\/wp\/v2\/tags?post=14961"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}